Delivery Order SPE2DB20D9329-SPE2DB25FZK98
- Not listed
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. The contract was awarded on August 25, 2025, with a firm fixed-price ceiling value of $6,028.88 and an ultimate completion date of September 16, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $17,574.41 to DMS Pharmaceutical Group Inc. on August 11, 2025, for the supply of EXPAREL 266 mg/20 mL vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this contract at its Park Ridge facility with an ultimate completion date of September 2, 2025. This delivery order was issued without a set-aside designation, allowing...
- The Defense Logistics Agency awarded a delivery order valued at $8,234.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, issued on August 28, 2025, with an ultimate completion date of September 19, 2025, was executed without a set-aside designation. The order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on July 24, 2025, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, valued at $50,212.60, is set to be completed by August 14, 2025, with performance taking place at the company's Park Ridge location. The award carries no set-aside designation, reflecting the contractor's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,021.26 for EXPAREL 1.3% 20ML (10 units) on August 18, 2025. This firm fixed-price delivery order was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. The awardee will perform this delivery at its Park Ridge, Illinois location, with an ultimate completion date of August 18, 2025....
- The Defense Logistics Agency awarded a $25,106.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 31, 2025, for the supply of EXPAREL 266 mg/20 mL vials. This delivery order, which carries an ultimate completion date of August 21, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million through November 2026. The award was made without set-aside designation, allowing DMS Pharmaceutical Group...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,531.89 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine product used for infiltration and nerve block anesthesia in surgical settings. The delivery order was awarded on August 20, 2025, with an ultimate completion date of September 11, 2025, and includes no...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of EXPAREL 133 mg/10 mL vials. The contract is valued at $6,092.20 with a firm fixed-price structure and an ultimate completion date of September 23, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete on an unrestricted basis....
- The Defense Logistics Agency awarded a $50,212.60 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and was awarded on August 5, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $25,106.30 firm fixed-price delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The contract carries an ultimate completion date of September 5, 2025, and involves no set-aside designation. This delivery order represents a continuation of DMS Pharmaceutical Group's substantial role...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB25FZK98Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $30,127.56 to DMS Pharmaceutical Group Inc. for EXPAREL 266 mg/20 ml vials on September 2, 2025. This firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be performed in Park Ridge, Illinois. The award carries no set-aside designation, and the product will be supplied to support Department of Defense healthcare operations. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, secured this delivery order under its larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The parent IDC enables DLA to issue firm fixed-price delivery orders for pharmaceutical products supporting military health facilities nationwide. EXPAREL, a liposomal bupivacaine anesthetic product, represents part of DMS Pharmaceutical Group's extensive portfolio of branded and generic pharmaceuticals, biologics, and medical consumables that have consistently positioned the company as a critical supplier within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.1k | 9/2/25 |